CASE REPORT article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
This article is part of the Research TopicCombination Cancer Therapies and Systems ImmunologyView all 6 articles
Surgical Treatment of the Patient with Locally Advanced Esophageal Cancer and Concurrent Thymoma After Neoadjuvant Therapy: A Case Report
Provisionally accepted
- Taihe Hospital, Hubei University of Medicine, Shiyan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Locally advanced esophageal squamous cell carcinoma (ESCC) can be treated effectively with surgical resection following downstaging via preoperative neoadjuvant therapy. This case report details the successful management of a patient with ESCC complicated by thymoma, who underwent two cycles of neoadjuvant therapy followed by surgery, resulting in improved survival. The patient initially presented with dysphagia and was diagnosed with ESCC at a local hospital, where gastroscopy revealed a neoplasm located 28–30 cm from the incisors. Pathological examination confirmed ESCC, and the clinical stage was cT2N2M0, stage III. The patient received chemotherapy (paclitaxel + cisplatin) combined with toripalimab at the local hospital but developed elevated thyroid hormone levels during treatment. Post-treatment enhanced chest CT scans at our institution showed a malignant tumor in the mid-to-lower esophagus, enlarged mediastinal lymph nodes, and an anterior mediastinal mass suggestive of thymoma, along with emphysema. Barium meal radiography indicated mild stiffness but good dilatation of the esophageal wall, with a normal cardia opening. Endoscopic ultrasound revealed ESCC invading the muscularis propria, chronic atrophic gastritis with erosion, and gastric xanthoma. Following multidisciplinary team (MDT) evaluation, the patient proceeded to thoracoscopic radical esophagectomy and resection of the mediastinal mass. Postoperative pathology showed ypT1bN2M0, stage IIIB, poorly differentiated ESCC with necrosis, measuring 2.5 × 1.6 × 0.4 cm, and invading the submucosa without vascular tumor thrombus or perineural invasion. Surgical margins, including those at the gastric resection site and proximal anastomosis, were free of tumor. Metastases were identified in the right recurrent laryngeal nerve chain and perigastric lymph nodes (2/4). The anterior mediastinal mass was confirmed as thymoma. Postoperative management included oxygen support, nebulization, analgesia, gastrointestinal decompression, antibiotics (piperacillin/cefradine), expectorants, antispasmodics, acid suppression, intravenous and enteral nutrition, and albumin supplementation. The patient recovered well and was discharged on postoperative day 12. Chemotherapy and radiotherapy were administered at the local hospital. During the 10-month follow-up, the patient remained recurrence-free and reported no dysphagia. This case provides valuable insights and therapeutic strategies for managing similar cases.
Keywords: Cancer nodules, esophageal squamous cell carcinoma, lymph node metastasis, Neoadjuvant Therapy, Thymoma
Received: 20 Sep 2025; Accepted: 09 Feb 2026.
Copyright: © 2026 Zhang, Zeng, Ren, Li and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Qiang Guo
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.